Israel - Hebräisch - Ministry of Health

kamada ltd, israel - cytomegalovirus antibody; human plasma protein; immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 96 %; human plasma protein 50 mg/ml; cytomegalovirus antibody 100 u/ml - cytomegalovirus immunoglobulin

Israel - Hebräisch - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

Israel - Hebräisch - Ministry of Health

csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 200 - 480 iu; coagulation factor vii (human) 100 - 250 iu; coagulation factor ix (human- rfixfc) 200 - 310 iu; coagulation factor x (human) 220 - 600 iu; protein c 150 - 450 iu; protein s antigen 120 - 380 iu - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - -treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Israel - Hebräisch - Ministry of Health

sanofi israel ltd - immunoglobulin rabbit anti-human thymocyte - אבקה להכנת תמיסה מרוכזת לעירוי - immunoglobulin rabbit anti-human thymocyte 25 mg/vial - antithymocyte immunoglobulin (rabbit) - antithymocyte immunoglobulin (rabbit) - immunosuppression in transplantation: prevention and treatment of graft rejection. treatment of acute graft versus host disease (gvhd). hematology treatment of aplastic anemia.

Israel - Hebräisch - Ministry of Health

dover medical & scientific equipment ltd, israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein; protein c; protein s antigen - אבקה וממס להכנת תמיסה לאינפוזיה - coagulation factor ix (human- rfixfc) 25 iu/ml; coagulation factor ii (human) 14 - 38 iu/ml; coagulation factor vii (human) 9 - 24 iu/ml; coagulation factor x (human) 18 - 30 iu/ml; protein 13 - 41 mg/ml; protein c 13 - 31 iu/ml; protein s antigen 12 - 32 iu/ml - coagulation factor ix, ii, vii and x in combination

Israel - Hebräisch - Ministry of Health

csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ii (human) 400 - 960 iu; coagulation factor vii (human) 200 - 500 iu; coagulation factor ix (human- rfixfc) 400 - 620 iu; coagulation factor x (human) 440 - 1200 iu; protein c 300 - 900 iu; protein s antigen 240 - 760 iu - coagulation factor ix, ii, vii and x in combination

Israel - Hebräisch - Ministry of Health

megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 1000 iu/vial - coagulation factor ix

Israel - Hebräisch - Ministry of Health

megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 2000 iu/vial - coagulation factor ix

Israel - Hebräisch - Ministry of Health

megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 250 iu/vial - coagulation factor ix

Israel - Hebräisch - Ministry of Health

megapharm ltd - coagulation factor ix (human- rfixfc) - אבקה וממס להכנת תמיסה להזרקה - coagulation factor ix (human- rfixfc) 3000 iu/vial - coagulation factor ix